SCHEMBL7985339

SCHEMBL7985339

COCc1nc2ncn(Cc3ccccc3)c2c(=O)[nH]1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.56
ALDH1A1 P00352 2/20 0.56
HPGD P15428 2/20 0.56
KMT2A Q03164 2/20 0.55
GAA P10253 1/20 0.47
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
BRD4 O60885 1/20 0.46
PNP P00491 2/20 0.44
PARN O95453 1/20 0.44
CNOT7 Q9UIV1 1/20 0.44
ADORA2B P29275 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
HCAR2 Q8TDS4 1/20 0.41
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975251 0.86 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7985469 0.84 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7989405 0.84 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7988094 0.84 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7984363 0.83 SMN1; SMN2 (0.59) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7974513 0.83 ADORA3 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
Hydrochloric Acid SCHEMBL7987463 0.83 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7987778 0.82 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7987608 0.82 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
Hydrochloric Acid SCHEMBL7992062 0.82 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HPGDKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed